Back to search

Article

Analytical Performances of the Point-of-Care BIOSYNEX COVID-19 Ag BSS for the Detection of SARS‐CoV‐2 Nucleocapsid Protein in Nasopharyngeal Swabs: A Prospective Field Evaluation During the COVID-19 Third Wave in France

2021-05-24

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Evaluating the accuracy and reliability of rapid diagnostic testing kits is crucial for surveillance and diagnosis of SARS-CoV-2 infections in general population. The aim of the study was to assess the analytical performances of the antigen-rapid diagnosis test (Ag-RDT) <italic>BIOSYNEX COVID-19 Ag BSS </italic>(Biosynex Swiss SA, Freiburg, Switzerland), targeti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
90c39793-6cff-541a-9a67-34241935ea04
DOI
10.21203/rs.3.rs-519746/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Analytical Performances of the Point-of-Care BIOSYNEX COVID-19 Ag BSS for the Detection of SARS‐CoV‐2 Nucleocapsid Protein in Nasopharyngeal Swabs: A Prospective Field Evaluation During the COVID-19 Third Wave in FranceDOI 10.21203/rs.3.rs-519746/v1
Select a neighboring publication to make it the new centre.